PVLA — Palvella Therapeutics, Inc. stock price, charts and financials

QT66Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc. (NASDAQ: PVLA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
150.56
-3.76-2.44%
PVLAQT66Palvella Therapeutics, Inc.·NASDAQ
150.56-2.44%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Sep 18, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 2026SC 13GBeneficial ownership statement (passive)
Aug 04, 20268-KCurrent report
Aug 04, 2026S-8Registration of employee benefit securities
Aug 04, 202610-QQuarterly report
Aug 03, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 14, 20268-KCurrent report
Jul 01, 20263Initial statement of beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 16, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership